ArticleOpen forum infectious diseases2023

Effectiveness of BA.1- and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan.

Takeshi Arashiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.